Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | E7820 |
Synonyms | |
Therapy Description |
E7820 is a derivative of aromatic sulfonamide that inhibits integrins, which may inhibit angiogenesis in tumors (PMID: 12414636). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
E7820 | E7820 is a derivative of aromatic sulfonamide that inhibits integrins, which may inhibit angiogenesis in tumors (PMID: 12414636). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ATR del | colorectal cancer | sensitive | E7820 | Preclinical - Cell culture | Actionable | In a preclinical study, E7820 inhibited viability of a colorectal cancer cell line with knockout of ATR in culture (PMID: 38789724). | 38789724 |
ATM del | colorectal cancer | sensitive | E7820 | Preclinical - Cell culture | Actionable | In a preclinical study, E7820 inhibited viability of a colorectal cancer cell line with knockout of ATM in culture (PMID: 38789724). | 38789724 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05024994 | Phase II | E7820 | A Study of E7820 in People With Bone Marrow (Myeloid) Cancers | Active, not recruiting | USA | 0 |